Circulating concentrations of interleukin‐18, interleukin‐18 binding protein, and γ interferon in patients with alcoholic hepatitis

Liver International - Tập 24 Số 6 - Trang 582-587 - 2004
Laurent Spahr1, Irene García2, Solange Bresson‐Hadni1, Laura Rubbia‐Brandt2, Reto Guler2, Maria L. Olleros2, Yolande Chvatchko3, Antoine Hadengue1
1Gastroenterology and Hepatology Unit,
2Department of Pathology, University Hospital, Geneva, Switzerland
3SERONO Pharmaceuticals Research Institute, Geneva, Switzerland

Tóm tắt

Abstract: Background: Alcoholic hepatitis (AH) is associated with dysregulated inflammatory and immune responses. interleukin‐18 (IL‐18), described as γ interferon (γIFN)‐inducible factor, and its natural antagonist, IL‐18 binding protein (IL‐18 BP), has not been fully studied in patients with AH. Thus, our aim was: (i) to determine plasma values of IL‐18, IL‐18 BP, γIFN, and tumor necrosis factor α (TNF)‐α in patients hospitalized for biopsy‐proven AH; (ii) to correlate these cytokines with the severity of AH, as assessed by Maddrey's discriminant function (DF), the degree of liver failure using the Child–Pugh score and blood neutrophils; (iii) to compare cytokines values in survivors and non‐survivors.

Methods: Cytokines were measured using specific immunoassays within 7 days of admission. The diagnosis of AH was based on histology in all cases. We studied 43 cirrhotic patients with a Maddrey's DF≥32 (severe AH), 29 patients with a score <32 (non‐severe AH), 12 patients with abstinent alcoholic cirrhosis, and 10 healthy subjects.

Results: IL‐18 and TNFα were increased in severe AH as compared with healthy subjects. Plasma IL‐18 BP was elevated in patients with severe and non‐severe AH as compared with healthy subjects. γIFN did not differ between groups. In patients with severe and non‐severe AH, IL‐18, IL‐18 BP, TNFα, but not γIFN, were positively correlated to DF and Child–Pugh score. Neither IL‐18 nor IL‐18 BP correlated to TNFα. Patients who died (n=10) during the hospitalization had higher IL‐18 BP and TNFα at admission as compared with survivors (322 [172–504] vs 222 [109–441] ng/ml; 7.5 [2.2–17.3] vs 3 [0.6–20] pg/ml, P<0.01, respectively).

Conclusion: In cirrhotic patients with AH, IL‐18, IL‐18 BP, and TNFα correlate to the hepatitis severity and to the degree of liver failure. High IL‐18 BP and TNFα at hospital admission in non‐survivors suggest it may be of prognostic value.

Từ khóa


Tài liệu tham khảo

Neumann M G, 2001, Mechanisms of alcoholic liver disease, cytokines, 25, 251S

10.1096/fj.00-0650rev

Spahr L, 2002, Combination of steroids with infliximab or placebo in severe alcoholic hepatitis, a randomized controlled pilot study, 37, 448

10.1016/S0168-8278(02)00442-7

10.1016/S0016-5085(99)70354-9

Sheron N, 1993, Circulating and tissue levels of the neutrophil chemotaxin Interleukin‐8 are elevated in severe acute alcoholic hepatitis, and tissue levels correlate with neutrophil infiltration, Hepatology, 18, 41

Rodriguez‐Rodriguez E, 1995, Cytokine levels in acute alcoholic hepatitis, a sequential study, 39, 23

10.1056/NEJM200011163432007

10.1136/gut.47.6.779

10.1034/j.1600-0528.2002.017418.x

10.1080/003655202320378347

International Group., 1981, Alcoholic liver disease, morphological manifestations. Review by an international group, 1, 707

10.1056/NEJM199202203260802

Mathurin P, 1998, Corticosteroid therapy in acute severe alcoholic hepatiti, the end of a controversy?, 22, 991

10.7326/0003-4819-110-9-685

10.1023/A:1020600230977

10.1046/j.1365-2249.2002.01911.x

10.1046/j.1440-1746.2002.02690.x

Mathurin P, 2002, Corticosteroids improve short‐term survival in patients with severe alcoholic hepatitis (AH), individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH, 36, 480

10.1002/bjs.1800600817

10.1006/cyto.2001.0914

10.1055/s-2007-1007110

10.1002/hep.1840130211

10.1016/S0168-8278(98)80227-4

10.7326/0003-4819-112-12-917

10.1016/S0140-6736(05)78614-1

10.1016/0016-5085(92)91122-K

10.1002/jmv.10445

10.1002/hep.1840180519

10.1016/0016-5085(93)90361-F

Goldie A S, 1995, Natural cytokine antagonists and endogenous antiendotoxin core antibodies in sepsis syndrome, the Sepsis Intervention Group, 274, 172